BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Cinnarizine

A piperazine derivative having histamine H1-receptor and calcium-channel blocking activity with vasodilating and antiemetic properties but it induces PARKINSONIAN DISORDERS.

299+ PubMed studies analyzed · 39 RCTs · Evidence Score: 46

Research Domains

Cinnarizine has been studied across 20 research domains including 🦴 Bone & Joint, 🧠 Focus & Attention, 🫁 Liver & Detox, 💊 Pain, 🧠 Neuroprotection. The primary research focus is 🦴 Bone & Joint with 20% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Cinnarizine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Promethazine
33 shared targets
Flunarizine
31 shared targets
Mianserin
28 shared targets
Cyproheptadine
30 shared targets
Amoxapine
33 shared targets
Trazodone
19 shared targets
Amitriptyline
31 shared targets
Nortriptyline
29 shared targets
Quetiapine
22 shared targets
Maprotiline
27 shared targets
Loading evidence profile...

This evidence profile for Cinnarizine is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.